Effect of chronic administration of cabergoline on uterine perfusion in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Fertility and Sterility

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0015-0282(98)00462-2PMID 9988404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome.

  1997cited by this paper
• The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.

  1996cited by this paper
• Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease.

  1996cited by this paper
• Transvaginal Doppler study of uterine artery blood flow in in vitro fertilization-embryo transfer cycles.

  1996cited by this paper
• Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome.

  1996cited by this paper
• Color Doppler analysis in lean and obese women with polycystic ovary syndrome

  1996cited by this paper
• Comparison of uterine blood flow characteristics between spontaneous and stimulated cycles before embryo transfer.

  1996cited by this paper
• Description of circadian rhythm in uterine artery blood flow during the peri-ovulatory period.

  1995cited by this paper
• The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome.

  1995cited by this paper
• Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.

  1995cited by this paper
• Polycystic ovary syndrome.

  1995cited by this paper
• Uterine and ovarian perfusion during the periovulatory period assessed by transvaginal color Doppler.

  1993cited by this paper
• Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process.

  1991cited by this paper
• Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone.

  1991cited by this paper
• Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles.

  1990cited by this paper
• Uterine and ovarian flow velocity waveforms in the normal menstrual cycle: a transvaginal Doppler study.

  1989cited by this paper
• POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE

  1989cited by this paper
• Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities.

  1987cited by this paper
• Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.

  1987cited by this paper
• Hyperprolactinemia in polycystic ovary syndrome.

  1984cited by this paper
• Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.

  1984cited by this paper
• Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids.

  1982cited by this paper
• Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats.

  1977cited by this paper

• Cabergoline monotherapy in polycystic ovary syndrome patients with elevated prolactin: a viable option?

  2025cites this paper
• Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management

  2024cites this paper
• Ovulation Induction in Patients with Polycystic Ovarian Syndrome (PCOS) & Hyperprolactinemia (HPRL): Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to (LE) Alone

  2021cites this paper
• The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology

  2020cites this paper
• The added effect of cabergoline to metformin on serum hormones and rate and regularity of menstruation in women with Polycystic ovary syndrome

  2018cites this paper
• Color Doppler analysis of uterine, spiral, and intraovarian artery blood flow before and after treatment with cabergoline in hyperprolactinemic patients*

  2015cites this paper
• Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia

  2015influential citation
• Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.

  2014cites this paper
• Effects of Cabergoline administration on uterine perfusion in women with polycystic ovary syndrome

  2013cites this paper
• Comparison of HOMA-IR, Uterine and Spiral Artery Resistance and Endometrium in PCOS Patient with Clomiphen Citrate and Naltrexone Treatment

  2013cites this paper
• Color doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome

  2007influential citation
• Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.

  2006cites this paper
• The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome.

  2002cites this paper
• Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome

  2002influential citation